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Abstract
           Current pacing practice is undergoing continuous and substantial changes. Initially pacing 
had an exclusively palliative role, since it was reserved for patients developing complete heart 
block or severe symptomatic bradycardia. With the appearance of novel pacing indications such 
as pacing for heart failure and atrial fibrillation, the effect of pacing site on cardiac function has 
become a critically important issue and a subject for consideration. It seems that the classical 
pacing site in the right ventricular apex is no longer the gold standard because of possible 
disadvantageous effects on cardiac function. The aim of this review article is to discuss the 
effect of right ventricular apical pacing on cardiac function including cellular and hemodynamic 
changes. We also aim to discuss the role of alternative pacing sites in the light of cardiac 
function. 
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Background:
            One of the most challenging tasks of modern pacing is to optimise or at least stabilize 
cardiac performance. This is clearly dependent on the important factors of chronotropic 
function, the quality of AV synchrony, the ventricular activation sequence and ventricular 
pacing site. Over the last 40 years stimulation of the right ventricular apex became the standard 
method for pacing the ventricles because it is a stable and easily accessible site, and usually 
provides appropriate sensing and threshold parameters1,2. Although it was quickly realised that 
stimulation of this site leads to an abnormal contraction pattern by bypassing the physiological 
conduction system, for pacing in patients with life-threatening conditions it still seemed 
appropriate. However, with the widening of classical pacing indications and the realisation that 
some patients developed deterioration of left ventricular function and sometimes heart failure 
after pacing, it became the subject of studies into its effect on left ventricular function.  
            The aim of this review is to provide insights into understanding how the pacing site may 
influence cardiac function. This may have an impact on selection of alternative locations for the 
right ventricular lead when preservation or even improvement of left ventricular function seems 
to be important for the patient.                                                                                                               
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Endocardial activation during right ventricular apical pacing:                                               
             During ventricular pacing the impulse conduction occurs predominantly through the 
working myocardium and the normal conduction system is bypassed. During right ventricular 
pacing the right ventricle is activated first followed by trans-septal activation of the left 
ventricle, then the remaining part of the left ventricle is activated. The QRS duration is 
increased, due to a combination of slow trans-septal activation (local and diffuse), and delayed 
activation of the remaining part of the left ventricle  3. A partial comparison can be drawn 
between the endocardial activation of patients with right ventricular apical pacing and patients 
with   LBBB,   although   there   are   some   differences.   In   patients   with   LBBB,   endocardial 
breakthrough of right ventricular activation is on the right ventricular septum and this occurs 
earlier than left ventricular breakthrough4. This means that right ventricular activation in patients 
with LBBB is normal for most patients4. Since in most patients the right ventricular lead is 
placed more antero-apically than septally, clearly the endocardial activation during right 
ventricular apical pacing is different, resulting in a more superior axis and even more 
intraventricular delay during the activation of the right ventricle. On the other hand the left 
ventricle is still activated trans-septally in patients with right ventricular apical pacing, however 
left ventricular breakthrough has a heterogeneous pattern in these patients, resulting in a 
somewhat different activation pattern to that observed during LBBB. In most patients with 
LBBB high septal breakthrough is most common4, whereas in most patients during RV apical 
pacing a single site of left ventricular breakthrough close to the ventricular apex is found. The 
presence of structural heart disease such as previous myocardial infarction may further increase 
the QRS duration during right ventricular apical pacing5. The effects of pacing site will also be 
different depending on whether intrinsic AV node conduction and thus fusion of activation 
patterns,   is   present6,7.                                                                
Effect of right ventricular apical pacing on the structure and function of the heart:  
            For many years the attention given to optimising the atrio-ventricular delay during dual 
chamber pacing has delayed an understanding of the importance of the effect of pacing site on 
global and regional myocardial function. This is despite the fact that diminished ventricular 
function during pacing at the right ventricular apex has been known for decades from numerous 
animal and human studies  8,9,10. Ventricular pacing results in an abnormal sequence of 
activation and this is associated with decreases in fiber shortening, contractile work, and 
myocardial blood flow and oxygen consumption in regions activated early and increases in these 
parameters in those regions with delayed activation 11,12,13. Studies have also confirmed that the 
early-activated regions are hypofunctional and the late activated regions are hyperfunctional. 
These differences are due to regional alterations in effective preload during asynchronous 
activation. The ventricular wall has to adapt to these changes. The asynchronous activation 
induces asymmetrical hypertrophy of the left ventricular wall. This asymmetric hypertrophy in 
itself however does not primarily influence the pump function. Abnormal electrical activation 
may thus lead to depressed left ventricular function12 by the classical theory of "loss of effective 
muscle mass". According to this theory, during ventricular pacing the ventricle looses a part of 
its effective muscle mass due to reduced function of the early-activated regions. An alternative 
or probably additional mechanism is that RV apical pacing results in inferior interventricular 
coupling, since during RV pacing the right ventricular pressure rises much earlier than that in 
the LV and this causes significant paradoxical septal motion10.                             
            Experimental animal data have also indicated that right  ventricular  apical  pacing may 
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decrease regional myocardial blood flow within the interventricular septum14,15. Prolonged 
compression of the septal arteries, as a result of the altered left ventricular depolarisation 
sequence was proposed as a possible explanation14,16. Extravascular compression is also a well-
known   determinant   of   coronary   blood   flow   during   the   basal   state   or   during   coronary 
vasodilation17. There is evidence, that aberrant and delayed depolarisation of the left ventricle 
can result in augmented intra-myocardial pressure in the septum, thus significantly affect 
myocardial perfusion in this region16. These animal data have been confirmed by human studies, 
where atrial and/or AV sequential pacing did not alter coronary flow reserve, however 
ventricular pacing decreased resting coronary flow velocity in some patients18. Furthermore, 
long term right ventricular apical pacing results in a high incidence of myocardial perfusion 
defects on nuclear studies. The magnitude of these defects was linearly proportional to the 
duration of pacing 19. These myocardial perfusion abnormalities are associated with apical wall 
motion abnormalities and impaired global left ventricular function19. Ventricular pacing also 
results in regional changes in tissue perfusion and heterogeneity between perfusion and 
sympathetic innervation20. Both ventricular and dual chamber pacing are associated with 
increase in cathecolamine activity20. Furthermore, so-called functional mitral regurgitation plays 
a crucial role in suboptimal hemodynamics. Right ventricular apical pacing causes significant 
intraventricular conduction delay. Segments of the left and right ventricle contract at different 
times and the interventricular septal wall contracts abnormally. This phenomenon results in 
decreased contractility, reduced diastolic filling and prolonged duration mitral regurgitation. The 
abnormal activation of the ventricles via right ventricular apical pacing may result in multiple 
abnormalities   of   cardiac   function,   which   may   ultimately   affect   clinical   outcome.    
Chronic   pacing   of   the   right   ventricular   apex   for   symptomatic   bradycardia      
            Acute clinical studies show that atrial pacing with preserved atrio-ventricular conduction 
and normal intraventricular conduction ensure better pump function at rest and a low pacing 
rates than DDD pacing with a restricted AV interval 21. Because of the lack of long term follow 
up these findings were not confirmed by clinical studies. On the other hand evidence has been 
growing that pacing at alternative pacing sites improves function and influences outcome as 
well22,23,24. The maintenance of atrio-ventricular synchrony is a critically important issue for 
these patients25. The risk of atrial arrhythmias and thrombo-embolic complications is clearly 
higher in VVIR paced patients than in AV sequentially or AAI paced patients specifically if AV 
conduction is preserved26. VA conduction is has been documented in 75% of the patients with 
SSS and even in more than 50% of the patients with complete AV block  27. Therefore 
maintenance of AV synchrony prevents "pacemaker syndrome". Improved exercise tolerance 
was also reported. Patients with SSS and VVI pacing are more likely to develop heart failure 
than with AAI pacing 26,28. One of the key targets of pacing therapy apart from mortality is 
improved QOL. Initially, DDD pacing seemed to be of most benefit in patients with high degree 
AV block and preserved sinus node function 29. However this hypothesis was not confirmed by 
recent multicenter study. Patients with SSS had more benefit from DDD pacing compared with 
VVI pacing, than patients with complete AV block 30. Another important issue, that may explain 
the controversial clinical data is related to the duration of right ventricular apical pacing. It 
seems that a longer duration of right ventricular pacing results in a more myocardial perfusion 
abnormalities19. Interestingly, this phenomenon seems to be reversible even after two years 
pacing 19,31. The duration of right ventricular pacing was also associated with the magnitude of 
decreased left ventricular ejection fraction. The reduced ejection fraction is mainly caused by an 
increased   left   ventricular   end-systolic   volume.                                                      
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Left ventricular function after AV node ablation and right ventricular apical pacing for 
patients   with   permanent   atrial   fibrillation:   Discordant   evolution   of   subjective   and 
objective   parameters                                                                    
             Patients with permanent atrial fibrillation undergoing AV node ablation and VVIR 
pacemaker implantation are optimal subjects for studying the effect of right ventricular apical 
pacing on left ventricular function for two reasons. First of all, these patients have no AV 
conduction, therefore the effect of AV delay does not influence the results; the effect of pacing 
site on the function could be studied independently. The other obvious reason is related to the 
concept of tachycardiomyopathy32. A relatively large proportion of these patients are suffering 
for   a   long   time   from   permanent   atrial   fibrillation.   Atrial   fibrillation   is   a   common 
supraventricular arrhythmia, which leads to cardiac dilatation and dysfunction in some patients - 
tachycardiomyopathy32. Theoretically, and practically in the majority of patients, ablation of the 
atrio-ventricular node followed by right ventricular apical pacing may result in an improvement 
of the patient's symptoms as well as in cardiac function because of the advantage of a regular 
ventricular response and adequate rate control32,33,34,35. However, variable results were reported 
about the course of patients following AV junction ablation. Although noticeable improvement 
in QOL has been reported, some other studies reported not improved or sometimes decreases left 
ventricular function34,36,37. An important aspect of these controversial data is that in most 
available large studies only data on the overall group was reported, despite the obvious fact that 
some patients deteriorated. After careful analysis of the data extracted from these studies, it 
seems that during the follow up, objective and subjective parameters showed somewhat of a 
discordant evolution. Correct interpretation of this data may allow us to develop a better 
understanding of the natural course of these patients and the reasons for this discordance. After 
AV node ablation numerous factors are influencing LV function. Some of them act in the 
direction of improvement, but some of them may cause deterioration. Regularisation and 
ventricular rate control appear to be the most important factors that may have an impact on 
improvement. On the other hand right ventricular apical pacing results in disadvantageous 
cellular changes and worsened hemodynamics. It seems so far, that the net effect of interplay 
between the beneficial and the worsening factors is unpredictable. The almost uniform 
improvement in quality of life supports the idea that subjective parameters are more influenced 
by the beneficial factors, however function react independently. In some patients, concordant 
with the QOL, function improves, however in others, despite the improvement in QOL, it may 
deteriorate. Therefore, in symptom control, regularisation and rate control are important factors, 
but their role in functional changes are not that clear. This variable outcome is of clinical 
significance as per the important question of Wood, as to whether AV node ablation is 
applicable to a wider spectrum of patients37. According to our experience and unpublished data 
we think that the effect of AV node ablation and right ventricular apical pacing on cardiac 
function is highly dependent on the baseline left ventricular ejection fraction. It seems that 
patients with preserved left ventricular function will more likely deteriorate their left ventricular 
function. Therefore, this therapy should be avoided in patients where only symptom control is 
the goal and who have normal cardiac function. This is in concordance with the concept of 
tachycardiomypoathy. It seems, that AV node ablation and right ventricular apical pacing is the 
best   for   patients   with   tachycardiomyopathy32.                                                  
Alternative pacing sites for preservation of left ventricular function: The possible role of 
high ventricular, left ventricular and biventricular pacing                                  
            As shown in previous trials, pacing of the right ventricular apex (the traditional   pacing 
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site) reduces LV function more than pacing the high ventricular septum or at LV sites8,9,38. 
Since pacing of these alternate sites results in a narrowed QRS complex as compared to RV 
apical pacing, synchronisation of electrical activation of the two ventricles seems to have a 
certain level of importance7,24. However, in some studies LV pacing without reduction of the 
QRS duration was more beneficial than biventricular pacing with marked reduction in QRS 
duration10. The study of Prinzen et al. showed improved hemodynamics with high ventricular 
septum pacing6, while Blanc and colleagues demonstrated improvement with LV pacing 
compared with RV apical pacing39. Biventricular pacing had a similar effect39. Interestingly 
enough, LV pacing alone was sufficient to improve LV function39. We can conclude from these 
studies that the pacing site probably has more influence on LV function than changes in the 
activation sequence itself. Certainly all of these studies were acute hemodynamic studies; 
therefore correlation with long-term results is still to be investigated. The mechanism of this 
action stems from the classical theory of "loss of effective muscle mass". According to this 
theory, during ventricular pacing the ventricle looses a part of its effective muscle mass due to 
reduced function of the early activated regions. Studies confirmed that the early-activated 
regions are hypofunctional and the late activated muscles are hyperfunctional. This results in a 
substantial degree of asynchrony. An alternative mechanism is that left ventricular pacing results 
in a superior interventricular coupling. During RV pacing the right ventricular pressure rises 
much earlier than during LV pacing and causes a significant paradoxical septal motion 10. 
            In conclusion, the ventricular pacing site has a major effect on ventricular function. It 
influences hemodynamics, initiates cellular changes and alters myocardial perfusion. These 
changes might result in left ventricular dysfunction in a considerable number of patients. Since 
the patients who develop dysfunction with pacing cannot be predicted according to our present 
knowledge, selection of alternative pacing sites, when the preservation and improvement of left 
ventricular function is important, should be considered during the routine clinical practice.
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